F
Fantasy VCFantasy VCSign in
DiscoverMarketsPortfolioActivity
F
Fantasy VCCommunity is the asset
Fantasy VC
DiscoverMarketsPortfolioActivity
SettingsHow it works
Sign in
F
Fantasy VCFantasy VC
DiscoverMarketsPortfolioActivity
Sign in
F
Fantasy VCFantasy VCSign in
Markets
CH

Celine Halioua

Loyal
@celinehalioua33.5K followersSan Francisco, CA

Founder and CEO of Loyal, the biotech pursuing the first FDA-approved drug to extend dog lifespan.

Founder and CEO of Loyal, the biotech pursuing the first FDA-approved drug to extend dog lifespan.

Price
$64.47
▼-40.93%today
Newstaller pin = bigger storyTap a pin to see headlines + price impact
Volume 24h
$205.9K
Holders
4,016
7d change
-40.89%

News

·2
+0.03
RD
loyal ceo celine halioua, this is nossos. she's an 8yo vizsla & was her mother's entire world until keston was born🔸we're very happy that your team is working their magic. pls work faster🔸if it'll help, pls take as much funding as possible from fundrise ceo & VCX architect ben miller
r/FundriseInvestors · 11h ago
HN
Next Dog May Live Longer
Hacker News · 23d ago

Recent trades

·0
No recent trades.

Career

  1. 2019–present
    Founder & CEO · Loyal
    Developing the first FDA-approved drug to extend dog lifespan.
  2. 2017–2019
    Chief of Staff · The Longevity Fund
    Worked with Laura Deming on early longevity-stage investing.
  3. 2017–2019
    DPhil Student · University of Oxford
    Studied health economics of gene therapy at St Peter's College.

About

Celine Halioua is the founder and CEO of Loyal, the biotech pursuing the first FDA-approved drugs to extend healthy lifespan — starting with dogs.

Accomplishments

  • Founded Loyal in 2019 at age 25 to extend canine healthspan
  • Earned the FDA's first-ever RXE for a lifespan-extension drug (LOY-001, 2023)
  • Earned the FDA's first known safety acceptance for a longevity drug (LOY-002)
  • Running the largest animal-health clinical trial ever — 1,300+ dogs at 70+ clinics
  • Trained as an Oxford health economist before founding Loyal

Pricing breakdown

Accomplishments50 · 35%
Mainstream popularity45 · 25%
Social popularity49 · 25%
X · 33.5K followers · 2.0 tweets/day · verified
Net worth40 · 15%
Composite
47/100
Intrinsic
$64.47
Market
+0.00%

Intrinsic price is set by the four-factor fundamentals score (35/25/25/15). Market price floats around it via a constant-product AMM — every trade moves the curve.

Tags

biohealthlongevity